Given SETD4's potential involvement in carcinogenesis, cancer advancement, and drug resistance, there is a pressing need to delve deeper into its significance in biological processes as well as its potential clinical relevance in cancer onset, progression, and treatment. The gene discussed is SETD4; the disease is cancer.